Elegance Optical International Holdings Limited (HKG:0907)
0.2040
-0.0060 (-2.86%)
May 16, 2025, 4:08 PM HKT
HKG:0907 Revenue
Elegance Optical International Holdings had revenue of 7.10M HKD in the half year ending September 30, 2024, with 18.39% growth. This brings the company's revenue in the last twelve months to 20.79M, down -12.85% year-over-year. In the fiscal year ending March 31, 2024, Elegance Optical International Holdings had annual revenue of 23.99M with 10.53% growth.
Revenue (ttm)
20.79M
Revenue Growth
-12.85%
P/S Ratio
8.57
Revenue / Employee
866.21K
Employees
26
Market Cap
178.06M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 23.99M | 2.29M | 10.53% |
Mar 31, 2023 | 21.70M | 6.43M | 42.09% |
Mar 31, 2022 | 15.28M | -38.66M | -71.68% |
Mar 31, 2021 | 53.93M | -12.32M | -18.59% |
Mar 31, 2020 | 66.25M | -112.71M | -62.98% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 32.53B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Alibaba Health Information Technology | 31.39B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Sino Biopharmaceutical | 30.72B |